Neuropeptide S vs TLQP-21 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...
Calculate Neuropeptide S dose →TLQP-21 is a 21-amino acid peptide derived from the C-terminal region of VGF (Nerve Growth Factor-Inducible), a large precursor neuropeptide that is proteolytically cleaved into multiple bioactive fragments. VGF is strongly induced by NGF and BDNF and plays roles in energy homeos...
Calculate TLQP-21 dose →| Parameter | Neuropeptide S | TLQP-21 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Preclinical | Research |
| Half-Life | Short (minutes, CNS) | Unknown |
| Typical Dose | 0.1-10 nmol (ICV, animal) | 1-100 nmol (animal) |
| Frequency | Variable | Variable |
| Route | Intracerebroventricular (animal research) | Intrathecal, Subcutaneous, Intracerebroventricular |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.